title: Serum superoxide dismutase levels of beta thalassemia patients and effects of high dosage of intravenous desferrioxamine treatment on superoxide dismutase levels.
authors.forename: M
authors.initials: M
authors.lastname: Tekin
authors.forename: N
authors.initials: N
authors.lastname: Akar
authors.forename: Y
authors.initials: Y
authors.lastname: Eğin
authors.forename: S
authors.initials: S
authors.lastname: Cin
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003676:Deferoxamine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008297:Male; D013482:Superoxide Dismutase / Q000097:blood*; D017086:beta-Thalassemia / Q000097:blood* / Q000188:drug therapy
chemical_list: D007502:Iron Chelating Agents; D013482:Superoxide Dismutase; D003676:Deferoxamine